Role of surgery in high-risk localized prostate cancer

Por Lawrentschuk, N., Trottier, G., Kuk, C., Zlotta, A.R.
Publicado em 2010

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer

Por Miah, S, Dudziec, E, Drayton, R M, Zlotta, A R, Morgan, S L, Rosario, D J, Hamdy, F C, Catto, J W F
Publicado em 2012

Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder

Por Hermanns, T, Bhindi, B, Wei, Y, Yu, J, Noon, A P, Richard, P O, Bhatt, J R, Almatar, A, Jewett, M A S, Fleshner, N E, Zlotta, A R, Templeton, A J, Kulkarni, G S
Publicado em 2014

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette–Guérin (BCG) in patients with superficial bladder c...

Por ZLOTTA, A R, DROWART, A, HUYGEN, K, DE BRUYN, J, SHEKARSARAI, H, DECOCK, M, PIRSON, M, JURION, F, PALFLIET, K, DENIS, O, MASCART, F, SIMON, J, SCHULMAN, C C, VAN VOOREN, J P
Publicado em 1997

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy

Por Boström, P.J., Thoms, J., Sykes, J., Ahmed, O., Evans, A., van Rhijn, B.W. G., Mirtti, T., Stakhovskyi, O., Laato, M., Margel, D., Pintilie, M., Kuk, C., Milosevic, M., Zlotta, A.R., Bristow, R.G.
Publicado no Bl Cancer (2016)